Evidence supporting the use of: Cineole
For the health condition: Wheezing
Synopsis
Source of validity: Scientific
Rating (out of 5): 3
Cineole (also known as eucalyptol) is a monoterpene and the principal active component of eucalyptus oil. Its use for treating or supporting wheezing, particularly in conditions like asthma and chronic obstructive pulmonary disease (COPD), is supported by a moderate amount of scientific evidence. Multiple clinical studies and reviews have demonstrated that cineole possesses anti-inflammatory, mucolytic, and bronchodilatory properties. These mechanisms can help reduce airway inflammation, decrease mucus production, and improve airflow, all of which are relevant to wheezing. For example, several randomized controlled trials have shown that oral administration of cineole (typically 200 mg three times daily) as an adjunct to standard therapy can significantly improve lung function, reduce exacerbations, and decrease dyspnea and wheezing in patients with asthma and COPD. The anti-inflammatory effect is thought to be mediated through the inhibition of cytokines and reduction of oxidative stress in the airways. Cineole is included in some over-the-counter preparations for respiratory conditions in Europe. However, the overall quality of evidence is moderate, as studies are limited in size and duration, and more large-scale, long-term trials are needed to confirm its efficacy and safety. Nevertheless, the current scientific data supports cineole’s use as a supportive therapy for wheezing, particularly as an adjunct to conventional treatments.
Other health conditions supported by Cineole
Allergies (respiratory)Asthma
Bronchitis
Colds (decongestant)
Colds (general)
Congestion
Congestion (bronchial)
Congestion (lungs)
Congestion (sinus)
Cough (damp)
Cough (dry)
Cough (general)
Cough (spastic)
Inflammation
Influenza
Laryngitis
Rhinitis
Rhinitis, Allergic
Sinus Infection
Wheezing